PMG
AMGN icon

ProVise Management Group’s Amgen AMGN Stock Holding History

ProVise Management Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.73M Sell
16,283
-25
-0.2% -$8.91K 0.41% 64
2025
Q4 		$5.34M Buy
16,308
+40
+0.2% +$12.7K 0.38% 65
2025
Q3 		$4.59M Sell
16,268
-93
-0.6% -$27K 0.34% 65
2025
Q2 		$4.57M Buy
16,361
+253
+2% +$71.7K 0.36% 63
2025
Q1 		$5.02M Sell
16,108
-112
-0.7% -$33.1K 0.43% 60
2024
Q4 		$4.23M Sell
16,220
-2,501
-13% -$742K 0.36% 69
2024
Q3 		$6.03M Sell
18,721
-153
-0.8% -$50K 0.48% 60
2024
Q2 		$5.9M Sell
18,874
-361
-2% -$106K 0.5% 55
2024
Q1 		$5.47M Sell
19,235
-2,197
-10% -$643K 0.47% 62
2023
Q4 		$6.17M Sell
21,432
-381
-2% -$104K 0.52% 55
2023
Q3 		$5.86M Sell
21,813
-333
-2% -$83.1K 0.55% 51
2023
Q2 		$4.92M Buy
22,146
+221
+1% +$51.3K 0.45% 65
2023
Q1 		$5.3M Sell
21,925
-567
-3% -$139K 0.51% 62
2022
Q4 		$5.91M Buy
22,492
+1,830
+9% +$491K 0.6% 54
2022
Q3 		$4.66M Buy
20,662
+2,318
+13% +$562K 0.52% 59
2022
Q2 		$4.46M Buy
18,344
+2,962
+19% +$726K 0.48% 65
2022
Q1 		$3.72M Buy
15,382
+3,473
+29% +$798K 0.35% 81
2021
Q4 		$2.68M Sell
11,909
-567
-5% -$120K 0.24% 107
2021
Q3 		$2.65M Buy
12,476
+1,222
+11% +$281K 0.26% 105
2021
Q2 		$2.74M Buy
11,254
+232
+2% +$57.1K 0.28% 95
2021
Q1 		$2.74M Sell
11,022
-7
-0.1% -$1.67K 0.3% 98
2020
Q4 		$2.54M Buy
11,029
+23
+0.2% +$5.3K 0.29% 95
2020
Q3 		$2.8M Sell
11,006
-407
-4% -$101K 0.37% 75
2020
Q2 		$2.69M Sell
11,413
-638
-5% -$146K 0.39% 75
2020
Q1 		$2.44M Sell
12,051
-191
-2% -$41.7K 0.41% 72
2019
Q4 		$2.95M Buy
12,242
+365
+3% +$80.5K 0.36% 81
2019
Q3 		$2.3M Buy
11,877
+404
+4% +$77.5K 0.3% 93
2019
Q2 		$2.11M Sell
11,473
-38,906
-77% -$6.97M 0.28% 100
2019
Q1 		$9.57M Sell
50,379
-2,021
-4% -$386K 1.34% 13
2018
Q4 		$10.2M Sell
52,400
-1,675
-3% -$327K 1.61% 9
2018
Q3 		$11.2M Sell
54,075
-610
-1% -$120K 1.48% 12
2018
Q2 		$20.2K Buy
54,685
+680
+1% +$120K 1.52% 16
2018
Q1 		$9.21M Sell
54,005
-35
-0.1% -$6.42K 1.36% 14
2017
Q4 		$9.4M Buy
54,040
+1,013
+2% +$179K 1.35% 16
2017
Q3 		$9.89M Buy
53,027
+1,828
+4% +$324K 1.43% 12
2017
Q2 		$8.82M Buy
51,199
+12,464
+32% +$2.03M 1.34% 16
2017
Q1 		$6.36M Buy
38,735
+6,158
+19% +$1.02M 1.02% 21
2016
Q4 		$4.76M Buy
32,577
+1,500
+5% +$226K 0.81% 33
2016
Q3 		$5.18M Buy
31,077
+10,500
+51% +$1.78M 0.9% 26
2016
Q2 		$3.13M Buy
20,577
+18,055
+716% +$2.81M 0.58% 52
2016
Q1 		$378K Hold
2,522
– – 0.08% 205
2015
Q4 		$409K Sell
2,522
-20
-0.8% -$3.14K 0.09% 194
2015
Q3 		$351K Hold
2,542
– – 0.08% 205
2015
Q2 		$390K Buy
2,542
+20
+0.8% +$3.2K 0.08% 202
2015
Q1 		$403K Sell
2,522
-50
-2% -$7.88K 0.09% 205
2014
Q4 		$410K Sell
2,572
-100
-4% -$15.6K 0.09% 209
2014
Q3 		$375K Hold
2,672
– – 0.08% 231
2014
Q2 		$316K Hold
2,672
– – 0.07% 255
2014
Q1 		$329K Hold
2,672
– – 0.08% 229
2013
Q4 		$305K Buy
2,672
+240
+10% +$27.3K 0.08% 235
2013
Q3 		$272K Buy
2,432
+260
+12% +$28.2K 0.08% 251
2013
Q2 		$214K Buy
+2,172
New +$225K 0.06% 292

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ProVise Management Group's AMGN Position: Q1 2026 in Review

ProVise Management Group reduced its Amgen (AMGN) stake by 0.15% in Q1 2026, selling an estimated $8.91K and leaving 16,283 shares worth $5.73M. The position accounts for 0.41% of the portfolio, ranked #64.

ProVise Management Group first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.2M in Q3 2018. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • ProVise Management Group held 16,283 shares of Amgen worth $5.73M as of Q1 2026.
  • ProVise Management Group sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
  • Amgen made up 0.41% of ProVise Management Group's portfolio in Q1 2026, its #64 holding.
  • ProVise Management Group first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • ProVise Management Group's Amgen position peaked at $11.2M in Q3 2018.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on ProVise Management Group's 13F filing for Q1 2026, filed 7 May 2026.